Investors
Contact
en
Global United States
Overview iTrack™ iTrack™ Advance Molteno3®
Overview Team AlphaRET
Overview ASX Announcements Presentations Share Registry Board of Directors Corporate Governance Capital Raise
  • Investors
  • Contact
  • Privacy Policy

    • Made with.
    Made for.
    Ophthalmologists.

    Nova Eye Medical designs, develops, manufactures and markets a portfolio of proprietary glaucoma treatment technologies. Underpinning each of these technologies is our commitment to advance clinical outcomes and improve patient quality of life.

    Learn More

    Lighting the way
    in canaloplasty

    Learn more

    Latest News

    See all

    iTrack Canaloplasty AGS 2025

    Media Release iTrack

    12 Feb, 2025

    Investor Presentation January 2025

    ASX Announcement General iTrack Molteno3 AlphaRET

    31 Jan, 2025

    December 2024 Quarterly Activities Report, Appendix 4C and Revenue Guidance

    ASX Announcement General iTrack Molteno3 AlphaRET

    31 Jan, 2025

    Superwomen
    in ophthalmology

    Every day thousands of women are making a positive, unique and important impact on the field of ophthalmology.

    Tell us your story!

    Latest Events

    See all

    American Glaucoma Society (AGS) 2025

    Washington, D.C.

    26 Feb - 2 Mar, 2025

    Register for updates

    American Society of Cataract and Refractive Surgery (ASCRS) 2025

    Los Angeles, California

    25 - 28 Apr, 2025

    Register for updates

    Kiawah Eye 2025

    Kiawah Island, United States

    29 - 31 May, 2025

    Register for updates

    Contact Us

    This website uses cookies to ensure you get the best experience on our website.
    The cookies do not store any personalised information. Learn More